News

Check back regularly for news and updates from SMFM.

Coding : Coding Tips Coding : Coding White Papers Press Publications & Guidelines Publications & Guidelines : Administrative Publications & Guidelines : Consult Series Publications & Guidelines : Endorsed Partner Pub Publications & Guidelines : Health Policy Publication Publications & Guidelines : Joint Publication Publications & Guidelines : Obstetric Care Consensus Publications & Guidelines : Public/Global Health Publications & Guidelines : SMFM Special Report Publications & Guidelines : SMFM Statement

Biomarker Prediction of Preeclampsia With Severe Features
Biomarker Prediction of Preeclampsia With Severe Features

Abstract This Clinical Practice Update provides guidance for the use of a biomarker immunoassay to aid in the risk assessment of certain pregnant women hospitalized for hypertensive disorders for the progression to preeclampsia with severe features. This document updates Practice Bulletin No.... Continue Reading

Postedby Society For Maternal-Fetal Medicine
Date posted04/3/2024


SMFM Consult #68: Sickle Cell Disease in Pregnancy
SMFM Consult #68: Sickle Cell Disease in Pregnancy

Abstract Pregnant individuals with sickle cell disease have an increased risk of maternal and perinatal morbidity and mortality. However, pre-pregnancy counseling and multidisciplinary care can lead to favorable maternal and neonatal outcomes. In this Consult, we summarize what is known about... Continue Reading

Date posted11/20/2023


Prophylactic low-dose aspirin for preeclampsia prevention—quality metric and improvement
Prophylactic low-dose aspirin for preeclampsia prevention—quality metric and improvement

SMFM Statement Continue Reading

Date posted11/9/2023


SMFM Consult #66: Pregnancy Evaluation & Management of Patients with Solid Organ Transplants
SMFM Consult #66: Pregnancy Evaluation & Management of Patients with Solid Organ Transplants

Abstract The rate of solid organ transplant in reproductive-aged patients has increased in the past 3 decades. Concurrently, the range of medical immunosuppressive agents has increased, making it safer for reproductive-aged individuals who have received transplants to attempt and continue a... Continue Reading

Date posted11/8/2023


SMFM Consult #64: Systemic lupus erythematosus in pregnancy
SMFM Consult #64: Systemic lupus erythematosus in pregnancy

Abstract The American College of Obstetricians and Gynecologists (ACOG) endorses this document. Systemic lupus erythematosus (SLE) is a chronic, multisystem, inflammatory autoimmune disease characterized by relapses (commonly called “flares”) and remission. Many organs may be... Continue Reading

Date posted01/1/2023


Telemedicine in obstetrics—quality and safety considerations
Telemedicine in obstetrics—quality and safety considerations

The frequency of telemedicine encounters has increased dramatically in recent years. This review summarizes the literature regarding the safety and quality of telemedicine for pregnancy-related services, including prenatal care, postpartum care, diabetes mellitus management, medication abortion,... Continue Reading

Date posted12/5/2022


SMFM Special Statement: Quality metric for timely postpartum follow-up after severe hypertension
SMFM Special Statement: Quality metric for timely postpartum follow-up after severe hypertension

Hypertensive disorders of pregnancy are a leading cause of maternal morbidity and mortality. Because postpartum exacerbation of severe hypertension is common, the American College of Obstetricians and Gynecologists recommends that patients with severe hypertension during the childbirth... Continue Reading

Date posted11/26/2022


SMFM Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy: The CHAP Trial
SMFM Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy: The CHAP Trial

Chronic hypertension occurs in approximately 2% of pregnancies in the United States and remains a major cause of maternal and perinatal morbidity and mortality. Specifically, chronic hypertension is associated with an increased risk of preeclampsia, pulmonary edema, acute kidney injury,... Continue Reading

Date posted11/12/2022


SMFM Special Statement: A quality metric for evaluating timely treatment of severe hypertension
SMFM Special Statement: A quality metric for evaluating timely treatment of severe hypertension

Severe hypertension in pregnancy is a medical emergency. Although expeditious treatment within 30 to 60 minutes is recommended to reduce the risk of maternal death or severe morbidity, treatment is often delayed by >1 hour. In this statement, we propose a quality metric that facilities can use... Continue Reading

Date posted11/8/2022


SMFM Responds to the Published Results of the CHAP Trial
SMFM Responds to the Published Results of the CHAP Trial

Washington, DC – The Society for Maternal-Fetal (SMFM) released the following statement in response to the published results of “Treatment for Mild Chronic Hypertension during Pregnancy,” in the New England Journal of Medicine. “SMFM has supported the 2019 guidelines from... Continue Reading

Date posted04/2/2022


High-Quality Diet in Pregnancy is Associated with a Lower Risk of Fetal Growth Restriction
High-Quality Diet in Pregnancy is Associated with a Lower Risk of Fetal Growth Restriction

Washington, DC ― Research has shown that an unhealthy diet during pregnancy can have long-term effects on a child’s health. Now, in a new study to be presented today at the Society for Maternal-Fetal Medicine’s (SMFM) annual meeting, The Pregnancy Meeting™, which is being held... Continue Reading

Date posted02/3/2022


ACOG-SMFM Practice Advisory: Low-Dose Aspirin to prevent Preeclampsia, Related Morbidity/Mortality
ACOG-SMFM Practice Advisory: Low-Dose Aspirin to prevent Preeclampsia, Related Morbidity/Mortality

Original Article TAGS: metabolic syndrome, cardiovascular disease, care of high-risk pregnancy, hypertension CATEGORIES: Joint Publication Continue Reading

Date posted12/23/2021